Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Index values follow a defined daily schedule so investors know when to expect updates. This brief explains the publication times and how to use the data in your investing routine.
21,512 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Federal Reserve Governor Michael S. Barr outlined three AI-driven labor-market futures, including a worst-case jobles...
Palantir has surprised and divided investors with big moves and bold AI promises. This guide explains what to watch, ...
Alphabet reportedly priced a rare 100-year bond to back AI and data-center expansion, a move that stirs debate on lon...
Can AI agents boost ethereum security? This piece explores a new testing ground where intelligent agents probe and pa...
Two dividend stocks double right now can help steady your income while you grow wealth. We break down two dependable ...
Affluent homeowners are shaping the remodeling outlook as 2026 approaches. Aging housing stock and increased equity b...
Pi Network confirms the long-anticipated network update finally, announcing a successful v19.6 migration and outlinin...
Older adults heading back to school are becoming the new majority student as they seek up-skilling and career changes...
EU officials press Washington to honor its trade commitments after a Supreme Court ruling sparks tariff chaos. The bl...
A pro-Ripple lawyer’s critique of a potential Sam Bankman-Fried pardon is shaping XRP traders’ views as price targets...
A fresh AI marketing platform is launching via Reg A+ at 0.85 per share, aiming to deliver rapid ROI for large brands...